Galatsis; Paul

Patent Applications and Registrations

Patent applications and USPTO patent grants for Galatsis; Paul.The latest application filed is for "novel imidazo[4,5-c]quinoline derivatives as lrrk2 inhibitors".

Company Profile

1.8.7

Galatsis; Paul - Newton MA
Galatsis; Paul - Ann Arbor MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors Grant 11,312,713 - Brodney , et al. April 26, 2	2022-04-26
Novel Imidazo[4,5-c]quinoline Derivatives As Lrrk2 Inhibitors App 20210355117 - BRODNEY; Michael Aaron ; et al.	2021-11-18
Cyclic substituted imidazo[4,5-c]quinoline derivatives Grant 11,161,844 - Chappie , et al. November 2, 2	2021-11-02
Cyclic Substituted Imidazo[4,5-c]quinoline Derivatives App 20200039977 - Chappie; Thomas Allen ; et al.	2020-02-06
Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors Grant 10,039,753 - Coffman , et al. August 7, 2	2018-08-07
3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors Grant 9,695,171 - Galatsis , et al. July 4, 2	2017-07-04
Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors Grant 9,642,855 - Galatsis , et al. May 9, 2	2017-05-09
Novel Imidazo[4,5-c]Quinoline And Imidazo[4,5-c][1,5]Naphthyridine Derivatives As LRRK2 Inhibitors App 20170073343 - Galatsis; Paul ; et al.	2017-03-16
NOVEL 3,4-DISUBSTITUTED-1H-PYRROLO[2,3-b]PYRIDINES AND 4,5-DISUBSTITUTED-7H-PYRROLO[2,3-c]PYRIDAZINES AS LRRK2 INHIBITORS App 20170002000 - Galatsis; Paul ; et al.	2017-01-05
Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d]Pyrimidines As LRRK2 Inhibitors App 20150366874 - Galatsis; Paul ; et al.	2015-12-24
4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors Grant 9,156,845 - Galatsis , et al. October 13, 2	2015-10-13
Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d] Pyrimidines As LRRK2 Inhibitors App 20140005183 - Galatsis; Paul ; et al.	2014-01-02
Arylsulfonamide ethers, and methods of use thereof Grant 6,875,765 - Knobelsdorf , et al. April 5, 2	2005-04-05
Arylsulfonamide ethers, and methods of use thereof App 20030096826 - Knobelsdorf, James ; et al.	2003-05-22
Hydroxamate inhibitors of interleukin-1.beta. converting enzyme Grant 5,919,790 - Allen , et al. July 6, 1	1999-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.